3Nio Y, Nagami H, Tamura K, et al. Multi - iustitutional randomized clinical study on the comparafve effects of intracavital chemotherapy alone versus immunotherapy alone versus immunochemotherapy for maligtant effusion[J]. Br J Cancer, 1999,80(5 - 6) :775 - 735.
4Kitsuki H, Katano M, Ikubo A,et al. Induction of inflammatory cytokines in effusion cavity by OK - 432 injection therapy for patients with malignant effusion: role of inter-feron- gamma in enhancement of surface expression of ICAM - 1 on tumor cells in vivo[ J]. Clin Immunol Immunopathol, 1996,78(3) :283 - 290.
5Katano M, Morisaki T. The past, the present and future of the OK - 432 therapy for patients with malignant effusions[J]. Anticancer Res, 1998,18(5D) :3917 - 3925.
二级参考文献4
1唐秀治 林玉娟 等.癌症症状征修护理[M].北京:科学技术文献出版社,1999.295-296.
2[1]Ogita S. Intracystic injection of OK - 432: a new sclerosing therapy for cystic hygrona in children[J]. Br J surg, 1987,74:690.
3[2]Torisv M. In OK - 432,clincial and experiment study in immuno-therapy. Excerpta Medica Amsterdam[M]. 1983.99 - 112.
1Katano M, Morisaki T. The past, the present and future of the OK-432 therapy for patients with malignant effusions[J].Anticancer Res,1998;18(5):3917-25.
2Nio Y, Nagami H, Tamura K,et al . Multi-institutional randomized clinical study on the comparative effects of intracavital chemotherapy alone versus immunotherapy alone immunochemotherapy for malignant effusion [J].Br J Cancer,1999:(5-6):775-85.
